These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 30210066)

  • 1. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
    Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
    J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge.
    Liu X; Yang Y; Sun Z; Chen J; Ai J; Dun C; Fu ZF; Niu X; Guo X
    PLoS One; 2014; 9(2):e87105. PubMed ID: 24498294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses.
    Plummer JR; McGettigan JP
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007800. PubMed ID: 31725816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs.
    McGettigan JP; David F; Figueiredo MD; Minke J; Mebatsion T; Schnell MJ
    Vaccine; 2014 Mar; 32(15):1716-9. PubMed ID: 24508037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Testing for immunogenic and protective properties of vaccine against tissue-inactivated rabies].
    Vrzal V; Cupera Z; Chumela J; Zatloukal L
    Vet Med (Praha); 1990 Feb; 35(2):87-95. PubMed ID: 2353410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice.
    Park JE; Shin HJ
    Vet Q; 2021 Dec; 41(1):202-209. PubMed ID: 33985418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.
    Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X
    Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice.
    Liu J; Sun J; Ding X; Liu W; Wang Y; Wang Z; Peng H; Zhang Y; Su W; Jiang C
    Emerg Microbes Infect; 2024 Dec; 13(1):2389115. PubMed ID: 39129566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of ERA strain of rabies virus propagated in a BHK-21 cell line.
    Lawson KF; Hertler R; Charlton KM; Campbell JB; Rhodes AJ
    Can J Vet Res; 1989 Oct; 53(4):438-44. PubMed ID: 2686831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single dose of an ALVAC vector-based RABV virus-like particle candidate vaccine induces a potent immune response in mice, cats and dogs.
    Meng X; Yan F; Wang W; Wang S; Cong H; Li J; Zhao Y; Wang T; Li N; Gao Y; Wang J; Feng N; Xia X
    Emerg Microbes Infect; 2024 Dec; 13(1):2406280. PubMed ID: 39295522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inactivated recombinant rabies CVS-11 virus expressing two copies of the glycoprotein elicits a higher level of neutralizing antibodies and provides better protection in mice.
    Xue XH; Zheng XX; Wang HL; Ma JZ; Li L; Gai WW; Wang TC; Yang ST; Xia XZ
    Virus Genes; 2014 Jun; 48(3):411-20. PubMed ID: 24535572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo.
    Norton JE; Lytle AG; Shen S; Tzvetkov EP; Dorfmeier CL; McGettigan JP
    PLoS One; 2014; 9(1):e87098. PubMed ID: 24489846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of the immune response to a vaccine as an alternative to the repetition of animal challenge studies for vaccines with demonstrated efficacy.
    Chapat L; Hilaire F; Bouvet J; Pialot D; Philippe-Reversat C; Guiot AL; Remolue L; Lechenet J; Andreoni C; Poulet H; Day MJ; De Luca K; Cariou C; Cupillard L
    Vet Immunol Immunopathol; 2017 Jul; 189():58-65. PubMed ID: 28669388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
    Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
    Luo J; Shi H; Tan Y; Niu X; Long T; Zhao J; Tian Q; Wang Y; Chen H; Guo X
    Vaccine; 2016 Aug; 34(37):4392-8. PubMed ID: 27449079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation of a Chinese ferret badger strain of rabies virus to high-titered growth in BHK-21 cells for canine vaccine development.
    Liu Y; Zhang S; Zhang F; Hu R
    Arch Virol; 2012 Dec; 157(12):2397-403. PubMed ID: 22886183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Interleukin-7 Extends the Humoral Immune Response Induced by Rabies Vaccination.
    Li Y; Zhou M; Luo Z; Zhang Y; Cui M; Chen H; Fu ZF; Zhao L
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.
    Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z
    Virol J; 2011 Sep; 8():454. PubMed ID: 21943337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs.
    Zhou M; Wang L; Zhou S; Wang Z; Ruan J; Tang L; Jia Z; Cui M; Zhao L; Fu ZF
    Oncotarget; 2015 Nov; 6(36):38504-16. PubMed ID: 26436700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.